Review The SDS Document
DOWNLOADProduct Details
Formula
C14H20N2O3
MW
264.33
Purity
>97%
Solubility (DMSO Mg/MI)
50
Bio Chemical Notes
Vorinostat (SAHA) was the first HDAC inhibitor approved by the FDA for cancer therapy. It has demonstrated inhibition of HDAC6, 8 and 10 over HDAC1, 2 and 3. Ref: J. Cellular Biochem 2009; 107 (4); 600-608.
![Vorinostat, SAHA, suberoylanilide hydroxamic acid [STAGING] Key Organics](https://staging.keyorganics.net/app/uploads/2026/01/Key-Organics-40th-logo-strip-1.png)
